Nephros Inc (NEPH) Stock Price & Analysis

Nephros Inc (NEPH) rose 2.70% to USD 4.18 as of September 8, 2026 at 14:53 UTC, according to Nexqual real-time market data.

NEPH last closed at USD 4.18; the session ranged USD 4.11–4.3 on volume of 11,053 shares. Market capitalization is —, with a 52-week range of USD 2.66–6.42 (NCM). Source: Nexqual, September 8, 2026 at 14:53 UTC.

Key Statistics (as of September 8, 2026 at 14:53 UTC)

Technical Analysis (NEPH)

Nexqual's technical model rates NEPH "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 14:53 UTC.

From Nephros Inc's Latest SEC 10-K Filing (filed 2026-03-12)

Key Strengths & Strategy (as disclosed to the SEC)

• If the FDA believes that we or any of our contract manufacturers, or regulated suppliers, are not in compliance with these requirements, there may be a material adverse effect on our manufacturing operations, affecting our ability to sell.   Regulatory Authorities in Regions Outside of the United States   We have obtained regulatory approvals to market certain medical filtration products outside of the United States, including in Canada and Brazil.
• Our methods of competition in the water filtration domain include:     Intellectual Property   Patents   We protect our technology and products through patents and patent applications.

Partnerships

• Under the License and Supply Agreement, as amended, Medica granted us an exclusive license, with right of sublicense, to market, promote, distribute, offer for sale and sell the filtration products worldwide, with certain limitations on territory, during the term of the License and Supply Agreement.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:53 UTC. This page is informational and not investment advice.